Updated Visitor Policy as of December 29, 2023: Learn More  
×
Affiliated Organizations
  HN Physicians   School of Nursing   HNH Fitness   Villa Marie Claire   Simulation Learning   Haiti Health Promise
Medical Partners Offices
Cardiovascular Specialists Pulmonary Specialists Obstetrics & Gynecology North Jersey Heart North Jersey Surgical Surgical Specialistss Primary Care Specialty Assoc. Urologic Specialties Women's Health Care

List of Clinical Studies

  201-541-6312    |      clinicalresearch@holyname.org

Vascular - Critical Limb Ischemia (CLI)

Study Name Principal Investigator
SAVAL – A phase 3, global, prospective, multicenter, 2:1 randomized trial evaluating the safety
John Rundback, MD

Vascular - Critical Limb Ischemia (CLI)

Study Name Principal Investigator
Abbott LIFE-BTK – Pivotal Investigation of Safety and Efficacy of BRS Treatment (Below the Knee) Randomized Controlled Trial.
Read more.
John Rundback, MD

Vascular - Native Arteriovenous Dialysis Fistulae (AVF)

Study Name Principal Investigator
TOBA II BTK – Tack Optimized Balloon Angioplasty study for the below the knee arteries using
John Rundback, MD

Vascular - Native Arteriovenous Dialysis Fistulae (AVF)

Study Name Principal Investigator
APV-IN.PACT AV Access – A randomized Study of IN.PACT™ AV Access Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon vs. Standard PTA for the Treatment of Obstructive Lesions in the Native Arteriovenous Dialysis Fistulae (AVF).
Read more.
Vincent Gallo, MD

Vascular - Peripheral Artery Disease (PAD)

Study Name Principal Investigator
TRANSCEND – SurVeil™ Drug-Coated Balloon – A prospective, multi-center, single-blind,
John Rundback, MD
OSPREY ILIAC – TIS2015-01 – Occlusive/Stenotic Peripheral artery Revascularization Study for Common and/or External Iliac Artery Using the Misago® RX Self-expanding Peripheral Stent.
Read more.
John Rundback, MD

Vascular - Venous Insufficiency

Study Name Principal Investigator
Vesper V-CA-001 – Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System (VIVID)
Read more.
John Rundback, MD